Urinary biomarkers and progression of AKI in patients with cirrhosis. - Wikidata - awgldk - TriplyDB

Urinary biomarkers and progression of AKI in patients with cirrhosis.

Urinary biomarkers and progression of AKI in patients with cirrhosis.

http://www.wikidata.org/entity/Q34455256

about

Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.Molecular phenotyping of clinical AKI with novel urinary biomarkers.Protecting the Kidney in Liver Transplant Recipients: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Biomarkers for the Early Detection and Prognosis of Acute Kidney Injury.Urine Interleukin 18 and Lipocalin 2 Are Biomarkers of Acute Tubular Necrosis in Patients With Cirrhosis: A Systematic Review and Meta-analysis.Advances in the Management of Acute Cardiorenal Syndrome in China: Biomarkers for Predicting Development and Outcomes.A mouse model of alcoholic liver fibrosis-associated acute kidney injury identifies key molecular pathways.Moderator's view: Patient-centered approaches for optimizing AKI management: the role of kidney biomarkers.Urinary Biomarkers at the Time of AKI Diagnosis as Predictors of Progression of AKI among Patients with Acute Cardiorenal Syndrome.Acute-on-chronic liver failure in cirrhosis.Fractional excretion of urea: A simple tool for the differential diagnosis of acute kidney injury in cirrhosis.Phenotyping of Acute Kidney Injury: Beyond Serum Creatinine.

P2860

Q28068137-4F152BCD-43E2-458C-AE41-393FC4FF76A4 Q30251763-7E9A5A90-A3EB-4323-BC77-3BC34F6624E0 Q35652638-B5AB867A-C143-456F-B57A-9AA24735C2C3 Q36017608-5D9F68F1-2054-4C25-AC3D-3EEF47624E1D Q38757060-8E7356F2-547A-42B1-A0E7-EF8CCCC96DD5 Q39003626-EC73F62F-A231-4C38-A915-E3FA350FB622 Q39053064-4F1CBE4F-BA7A-4823-B1B1-65E87351C091 Q39148695-C6BF1155-9E6C-4883-A85F-063ABF9D30D4 Q39376604-2D62C3ED-5376-41BE-AC96-110DE601588B Q40259182-CEEF7F7F-5B70-4604-BF76-8560F841841E Q41022451-1B35E362-3448-46C5-B07C-FA0EEF798B1F Q46095596-BBDC1F54-6D36-46B7-AFDA-9BB5CAAE0BC8 Q48282636-D670DBB2-279E-4093-B14B-581693F829E4 Q52733199-05CCEB7B-E592-4424-9F42-59C1078E5274

P2860

Urinary biomarkers and progression of AKI in patients with cirrhosis.

http://www.wikidata.org/entity/Q34455256

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Urinary biomarkers and progression of AKI in patients with cirrhosis.

@ast

Urinary biomarkers and progression of AKI in patients with cirrhosis.

@en

Urinary biomarkers and progression of AKI in patients with cirrhosis.

@nl

type

label

Urinary biomarkers and progression of AKI in patients with cirrhosis.

@ast

Urinary biomarkers and progression of AKI in patients with cirrhosis.

@en

Urinary biomarkers and progression of AKI in patients with cirrhosis.

@nl

prefLabel

Urinary biomarkers and progression of AKI in patients with cirrhosis.

@ast

Urinary biomarkers and progression of AKI in patients with cirrhosis.

@en

Urinary biomarkers and progression of AKI in patients with cirrhosis.

@nl

P1433

Q34455256-13145DC1-6AE4-48FC-8BC4-218CEE4B215F

P1476

Q34455256-ECC371F0-E753-4232-9977-A5974804DC5B

P2093

Q34455256-130616FD-B763-4C8D-A7C3-5DC0EA1727B7

Q34455256-18EEA7B6-566D-4D5B-9F7E-161F70018E18

Q34455256-3195C6A3-024B-4028-8666-B009F28C7F76

Q34455256-4A27AC74-7EAD-404D-BA4B-2483BB6743EC

Q34455256-4A4E6AA1-CA8B-480A-9BC7-7275B1F4C9B9

Q34455256-5E9CCB5A-5068-416B-8B99-9B830A80E519

Q34455256-8C84CBC6-9E89-4EBA-A6A9-2812DCC8793F

Q34455256-8DC724F1-C52D-4561-8B6B-DD802BE00656

Q34455256-D50CC936-BEBA-4BD3-BD57-3647B3BB8AB6

P2860

Q34455256-0D6AA6EC-C1BC-4F71-8713-79FA4C75DCC8

Q34455256-16107CFF-E0AC-45DD-B59A-1D00D4CCF40C

Q34455256-16C5893D-1330-4008-931C-3F8F449D357C

Q34455256-2FC2B1DC-C0DF-44F2-B4E8-3362BE27B7A7

Q34455256-39879BD9-781F-4D53-B8E2-4E0F9E90F389

Q34455256-3AECD036-83DF-48A0-A4C6-A1FF3D21C163

Q34455256-406EB2B5-7A85-424C-8E24-A65DAE8F075D

Q34455256-44FE0319-E772-4EC5-B40E-1D9D538E86C2

Q34455256-45027119-DDC9-4AD4-904B-9E8E39D93144

Q34455256-56E0BC13-5055-4A9A-BA52-10D65A362B3C

P304

Q34455256-05A86577-7C10-426B-8722-B7AA1287F90B

P31

Q34455256-229E8559-69D5-4982-B53A-5DF6BB8F97A7

P356

Q34455256-C7E0223F-A5EF-4A10-994D-7C096D024753

P433

Q34455256-71F938EF-9ED9-4895-8EC5-4DD9E7E88C89

P478

Q34455256-506208DA-E00C-4D8F-B29D-D8D50AFB5445

P50

Q34455256-347ECB82-D56B-41A0-BDDA-58F7B506A954

Q34455256-E5C83EAE-3BD1-44A2-A836-DA9CE1D7DB74

P577

Q34455256-CD63720E-A673-4C48-A94E-763809DE392C

P698

Q34455256-13748139-02CC-49E1-AE42-0E9E62CA0EFB

P921

Q34455256-BF5E7994-DCB0-4457-A2F5-9FAE46C0D96D

P932

Q34455256-57CBACA2-6E12-4162-BBB3-5C7941F1143E

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Urinary biomarkers and progression of AKI in patients with cirrhosis.

@en

P2093

Aldo J Peixoto

http://www.w3.org/2001/XMLSchema#string

Arun J Sanyal

http://www.w3.org/2001/XMLSchema#string

Chirag R Parikh

http://www.w3.org/2001/XMLSchema#string

Guadalupe Garcia-Tsao

http://www.w3.org/2001/XMLSchema#string

Joseph Lim

http://www.w3.org/2001/XMLSchema#string

Justin M Belcher

http://www.w3.org/2001/XMLSchema#string

Mark A Perazella

http://www.w3.org/2001/XMLSchema#string

Naheed Ansari

http://www.w3.org/2001/XMLSchema#string

Steven G Coca

http://www.w3.org/2001/XMLSchema#string

P2860

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Pretransplant predictors of recovery of renal function after liver transplantation.

IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation.

Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.

Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes

Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury.

The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies.

Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis.

Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation.

Biomarkers predict progression of acute kidney injury after cardiac surgery.

P304

1857-1867

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.09430913

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Heather Thiessen-Philbrook

TRIBE-AKI Consortium

P577

2014-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25183658

http://www.w3.org/2001/XMLSchema#string

P921

P932

4220770

http://www.w3.org/2001/XMLSchema#string